MP

Meenu Parmar

Active Director Director DIN 05242035
DIN 05242035 First appointment Apr 2012 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2012
Shareholding value •••• Premium profile

About Meenu Parmar

Data last updated:

Meenu Parmar is a Director at Four Seasons Pharmaceuticals Private Limited (since 2012). The company operates in Chemicals. Four Seasons Pharmaceuticals Private Limited reported revenue of ₹1.30 Cr (FY 2025).

DIN 05242035
Primary Designation Director
Industry Chemicals
First Appointment 04 Apr 2012
Oldest Company Age 14 yrs
Largest company Four Seasons Pharmaceuticals Private Limited · ₹1.30 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Apr 20122012₹1.30 Cr (FY 2025)Active

Board colleagues of Meenu Parmar

Directorship timeline

Open interactive timeline →
Four Seasons Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Meenu Parmar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenu Parmar

Meenu Parmar currently holds 1 directorship: Four Seasons Pharmaceuticals Private Limited (Director, since 04 Apr 2012, revenue ₹1.30 Cr (FY 2025)).

Meenu Parmar was first appointed on 04 Apr 2012 as Director at Four Seasons Pharmaceuticals Private Limited.

The current boards of Meenu Parmar's companies include Jaspal Singh Parmar (Four Seasons Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available